In this webinar, learn to transform raw clinical and biobanking data into research-ready assets to accelerate pharmaceutical R&D.
Discover how data generated during patient care can be transformed into high-value assets to accelerate pharmaceutical research. In this webinar, we will explore how integrating the care pathway, pathology data, biobanking, and data structuring makes it possible to produce reliable, high-quality clinical datasets that are directly usable and aligned with the needs of pharmaceutical R&D.
Key Topics Include:
- Understand the full value chain of a clinical asset
- Identify the key stages that can impact the value of the final deliverable
- Assess the conditions required to produce a usable and research-ready dataset
Presenters
Vice President
Medipath
Dr. Nicolas Weinbreck is a pathologist and serves as Chief Executive Officer and Vice President of the Medipath Group. A recognized expert in anatomical and cytopathology, he specializes in soft tissue sarcomas. Strongly involved in issues related to quality, innovation, and the structuring of pathology practices in France, he also holds several national representative positions, notably within the CNPath and the SMPF. He regularly contributes to reference work, scientific publications, and educational activities dedicated to oncology and precision medicine.
Biobank Manager
France Tissue Bank
Caroline Rancati graduated with a Master's degree in biobanking and the use of associated data. She has been working in this field for 4 years specializing in the management and coordination of projects that require the sourcing of HBS and/or associated data.
Biobank Manager
France Tissue Bank
Pauline Mespoulhé is a biobank and health data expert specializing in the valorization of human biological samples and their integration into innovative research projects. She supports biotech, pharma, medtech, and academic teams in ensuring scientific, regulatory, and strategic alignment to strengthen project quality and impact.
Production Partner
France Tissue Bank
France Tissue Bank supports the scientific community by meeting the needs of research teams by providing biological resources to carry out their development with excellence. Specialised in human biological tissues and mainly in oncology, FTB meets the needs of facilities in a personalised way, by supplying FFPE blocks, white and stained histological slides, digital images, and gynaecological pap smears; providing a set of robust data related to these samples; and offering a range of tailor-made laboratory services: slide scannings, standard and specific stainings, immuno-stainings, and molecular pathology tests.
Additional Content From France Tissue Bank
Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
In this webinar, experts explore how high-quality biospecimens, longitudinal data, and regulatory rigor drive the future of biomarker discovery and clinical diagnostics.
COMPLi HBS Legislation Series: France
This webinar explores France's governance of human biological samples for research, focusing on acquisition, storage, import/export, and unique requirements in comparison to global standards.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Related Content
Engineering Neuromodulation for Cardiovascular Instability
Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition
Join Professor Luke O’Neill (Trinity College Dublin) and Dr Elise Malavasi ( Associate Director of Neurosciences Concept Life Sciences) for this webinar that explores recent advances in inflammasome science, and highlights how selecting appropriate in vitro models and meaningful readouts is essential for accurately assessing therapeutic potential.
Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform
In this webinar, Dr. Lei Shi introduces Biointron's antibody discovery platform and applications.